← European Medicine Shortage Tracker · all medicines

Cyclophosphamide shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Cyclophosphamide currently has availability issues reported in 6 European registers: Austria, Germany, Spain, EU-wide, France, Italy.

Shortage  ATC L01AA01 · also listed as: CYCLOPHOSPHAMID · Cyclophosphamid Monohydrat · CICLOFOSFAMIDA · cyclophosphamide · CICLOFOSFAMIDE · data refreshed 10 September 2026

Key facts

As of 10 September 2026, 6 of the 9 tracked registers list current availability issues for Cyclophosphamide, covering 16 affected product presentations. The longest-running open report was filed in Austria on 2025-10-14 and has now been open for about 11 months. Where agencies state a cause, manufacturing problems lead with 5 of the 8 stated-cause reports, followed by active-ingredient (API) supply issues with 2. The furthest expected-resolution date currently on file is 2028-01-03; the earliest is 2026-09-16. The issue spread across registers over time rather than at once: Austria reported first (2025-10-14), with the EMA catalogue following roughly 4 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Cyclophosphamide is coded L01AA01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

Shortage Listed in the EMA shortages catalogue — EU-level issue. EMA record ↗
WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇺 EU-wide (EMA)Shortage
Cyclophosphamide
2026-02-24Cancerregister ↗
🇦🇹 AustriaShortage
Cyclophosphamid Sandoz 1000 mg – Pulver zur Herstellung einer Injektions-/Infusionslösung
+ 4 more products
Cyclophosphamid Sandoz 2000 mg – Pulver zur Herstellung einer Injektions-/Infusionslösung
Endoxan "Baxter" 1 g - Trockenstechampulle
Endoxan "Baxter" 200 mg - Trockenstechampulle
Endoxan "Baxter" 500 mg - Trockenstechampulle
2025-10-14register ↗
🇩🇪 GermanyShortage
Cyclophosphamid HEXAL 500 mg
+ 3 more products
Endoxan 1 g
Endoxan 200 mg
Endoxan 500 mg
2026-01-212026-12-31Erhöhte Nachfrage
Alternatives: N/A
register ↗
🇪🇸 SpainShortage
CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 1 ml
+ 1 more products
CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial
2026-02-012028-01-03Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇫🇷 FranceLimited availability
Endoxan 50 mg, comprimé enrobé
+ 1 more products
Endoxan 500 et 1000 mg, poudre pour solution injectable
Oncologie/Radiothérapie, Rhumatologieregister ↗
🇮🇹 ItalyShortage
ENDOXAN BAXTER
+ 1 more products
ENDOXAN BAXTER
2025-12-232026-09-30Elevata richiesta/problemi produttivi: distribuzione contingentata
Alternatives: AIFA: import of a foreign equivalent can be authorised.
register ↗

New register reports per month

2025-10: 22025-11: 02025-12: 12026-01: 32026-02: 62026-03: 02026-04: 12026-05: 02026-06: 02026-07: 02026-08: 12025-102026-08

Full report history (16 register entries)

Every individual register entry for Cyclophosphamide in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITENDOXAN BAXTERShortage2026-08-17Problemi produttivi
🇩🇪 DECyclophosphamid HEXAL 500 mgShortage2026-04-232026-09-16Erhöhte Nachfrage
🇦🇹 ATEndoxan "Baxter" 1 g - TrockenstechampulleLimited availability2026-02-25
🇦🇹 ATEndoxan "Baxter" 200 mg - TrockenstechampulleLimited availability2026-02-25
🇦🇹 ATEndoxan "Baxter" 500 mg - TrockenstechampulleLimited availability2026-02-25
🇪🇺 EUCyclophosphamideShortage2026-02-24Cancer
🇪🇸 ESCICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABShortage2026-02-092028-01-03
🇪🇸 ESCICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARAShortage2026-02-01Existen otros medicamentos con el mismo principio activo y m
🇩🇪 DEEndoxan 1 gShortage2026-01-212026-12-31Probleme in der Herstellung
🇩🇪 DEEndoxan 200 mgShortage2026-01-212026-12-31Probleme in der Herstellung
🇩🇪 DEEndoxan 500 mgShortage2026-01-212026-12-31Probleme in der Herstellung
🇮🇹 ITENDOXAN BAXTERShortage2025-12-232026-09-30Elevata richiesta/problemi produttivi: distribuzione conting
🇦🇹 ATCyclophosphamid Sandoz 1000 mg – Pulver zur Herstellung einer InjektioShortage2025-10-14
🇦🇹 ATCyclophosphamid Sandoz 2000 mg – Pulver zur Herstellung einer InjektioShortage2025-10-14
🇫🇷 FREndoxan 50 mg, comprimé enrobéLimited availabilityOncologie/Radiothérapie, Rhumatologie
🇫🇷 FREndoxan 500 et 1000 mg, poudre pour solution injectableLimited availabilityOncologie/Radiothérapie

Frequently asked

Is Cyclophosphamide currently in shortage in Europe?

Yes. As of 10 September 2026, availability issues are reported in: Austria, Germany, Spain, EU-wide (EMA), France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Cyclophosphamide shortage expected to end?

Agency prognoses on file range from 2026-09-16 to 2028-01-03. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Cyclophosphamide?

7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Cyclophosphamide availability data come from?

Directly from the official medicines-agency registers that list Cyclophosphamide: BASG (Austria), BfArM (Germany), AEMPS CIMA (Spain), EMA shortages catalogue (EU), ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cyclophosphamide — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cyclophosphamide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cyclophosphamide availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cyclophosphamide/">Cyclophosphamide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Cyclophosphamide: availability status across 6 European registers — European Medicine Shortage Tracker (MobiDoctor), 10 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.